Glenmark Pharmaceuticals Has Received Final Approval From The US - Dollar Advisory Financial Services

Breaking

Monday 20 November 2017

Glenmark Pharmaceuticals Has Received Final Approval From The US

Glenmark Pharmaceuticals has received final approval from the US health regulator for generic version of Loestrin tablets used to prevent pregnancy.

"Glenmark Pharmaceuticals USA has been granted final approval by the US Food and Drug Administration for Hailey 24 Fe (Norethindrone Acetate and Ethinyl Estradiol tablets, USP and Ferrous Fumarate tablets), 1 mg/20 mcg, the generic version of Loestrin 1 24 Fe tablets, of Allergan Pharmaceuticals," the company said in a filing.

The 30-share BSE Sensex was down 30.71 points at 33,312.09 and the 50-share NSE Nifty declined 15.80 points to 10,267.80.

For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory

No comments:

Post a Comment